SODIUM PHENYLACETATE AND SODIUM BENZOATE
Peaksodium phenylacetate and sodium benzoate
NDAINTRAVENOUSSOLUTION
Approved
Jun 2021
Lifecycle
Peak
Competitive Pressure
30/100
Data completeness
3/8 — Basic
SODIUM PHENYLACETATE AND SODIUM BENZOATE (sodium phenylacetate and sodium benzoate) by MAIA Biotechnology is enzymes: n -acetylglutamate synthetase (nags), carbamyl phosphate synthetase (cps), argininosuccinate synthetase (ass), ornithine transcarbamylase (otc), argininosuccinate lyase (asl), or arginase (arg). Approved for hepatic encephalopathy. First approved in 2021.
Drug data last refreshed 18h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Sodium phenylacetate and sodium benzoate is an intravenous solution that treats hepatic encephalopathy by providing an alternative nitrogen disposal pathway in patients with urea cycle disorders. The drug works by enabling phenylacetate to conjugate with glutamine and benzoate to conjugate with glycine, allowing waste nitrogen excretion without a fully functioning urea cycle.
Peak
Product is in peak revenue phase with moderate competitive pressure (30%), indicating stable commercial operations and an established field presence.
Mechanism of Action
enzymes: N -acetylglutamate synthetase (NAGS), carbamyl phosphate synthetase (CPS), argininosuccinate synthetase (ASS), ornithine transcarbamylase (OTC), argininosuccinate lyase (ASL), or arginase (ARG). Sodium phenylacetate and sodium benzoate are metabolically active compounds that can serve as…
Indications (1)
Worked on SODIUM PHENYLACETATE AND SODIUM BENZOATE at MAIA Biotechnology? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.